Screener
Humacyte HUMA Q1 2026 earnings
Reported May 13, 2026 · Before market open
Revenue$495.0KMiss by $968.7K
EPS-$0.09Beat by $0.01
Revenue estimate$1.5M
EPS estimate-$0.10
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$769.4K
EPS estimate-$0.09
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Humacyte report Q1 2026 earnings?
- Humacyte (HUMA) reported Q1 2026 earnings on May 13, 2026 before market open.
- What were Humacyte's Q1 2026 revenue and EPS?
- Humacyte reported revenue of $495.0K and eps of $-0.09 for Q1 2026.
- Did Humacyte beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $1.5M by $968.7K. EPS beat the consensus estimate of $-0.10 by $0.01.
- How did Humacyte's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 4.3% from $517.0K a year earlier and eps grew 10.0% from $-0.10.
- Where can I find Humacyte's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-221755) directly on SEC EDGAR. The filing index links above go to sec.gov.
